European TICC group, Normec, Gains Foothold in US Market with Three Strategic Acquisitions

Cagkan - stock.adobe.com

The Netherlands-based Normec, a European provider of Testing, Inspection, Certification, and Compliance (TICC) services, announced on Aug. 6, 2025 that it has entered the US market with three acquisitions. The acquisitions involve highly specialized companies in the foodcare, sustainability, and healthcare sectors. Normec is backed by Astorg, a pan-European private equity firm, which has been the majority shareholder of the group since 2020 (1).

The acquired US companies include Champaign, Ill.-based MS Bio, Philadelphia-based MJ Reider, and Hamden, Conn.-based NorthEast BioLab.

Founded in 2018, MS Bio is a nutrition supplement-focused testing lab that serves manufacturers and producers in the dietary supplement, functional food, and cosmetics industries using its microbiological and several other testing methods. MJ Reider was established in 1952 as a full-service water testing laboratory. It offers comprehensive analyses across microbiology, inorganic and organic compounds, per- and polyfluoroalkyl substances (PFAS), and dioxins. NorthEast BioLab, founded in 2003, is a Clinical Laboratory Improvement Amendments-certified bioanalytical laboratory that supports the biopharmaceutical sector across all stages of drug development—from discovery to clinical trials. The labs’ clients include biotech firms, pharmaceutical companies, research institutions, and contract research organizations.

Benefits of acquisitions

“Today’s announcement marks a pivotal moment in Normec’s journey and more than doubles our addressable market. With a Group valuation now exceeding €2 billion [US$2.3 billion], the addition of these three businesses, each known for deep technical expertise, customer trust, and unwavering commitment to quality, provide a strong foothold in the world’s largest TICC market. We see a significant opportunity to continue to grow both organically and inorganically across the [United States] and internationally as we continue to execute on our growth strategy,” said Joep Bruins, CEO of Normec, in a company press release (1).

With the specialized capabilities of these three labs, Normec strengthens its expertise across bioanalysis, water quality, and nutritional testing. The group can now serve clients across Europe and North America, allowing it to offer expert compliance services in complex, regulated environments.

The TICC industry is a global market valued at more than €200 billion (2), and Normec enables organizations to innovate safely, quickly, and cost-efficiently across this industry. With these three acquisitions, Normec gains a foothold in the US, the largest TICC market worldwide, according to Normec. The acquisitions more than double its addressable market and boosts its position as an international specialist TICC platform that offers expertise across four highly regulated and fast-growing end markets, including food, life safety, sustainability, and healthcare.

Entry into the US TICC market marks the fifth entry into a new geography by the group over the past five years. Normec views the US TICC market as being highly fragmented, which presents attractive opportunities for further consolidation, the group stated in its press release.

“We are proud to partner with Normec since 2020 and to support the Group’s strong growth. Normec has successfully entered five new markets in the [p]ast five years and has completed [more than] 85 acquisitions since 2016. Entering the US is a landmark milestone in the Group’s evolution into a global TICC platform and the next step in the mission to deliver a specialized approach to compliance, operational excellence and sector depth globally,” said Benjamin Cordonnier, co-managing partner and CEO of Astorg, in the press release.

References

1. Normec. European TICC Leader Normec Enters US with Three Strategic Acquisitions. Press Release. Aug. 6, 2025.
2. Drazdou, F. TIC Industry: Complete Guide to Testing, Inspection & Certification Market. aventis-advisors.com, July 10, 2025.